2.4.0.82403403 - Disclosure - Equity Method Investments (Detail) - Condensed Financial Information of the Company's Non-Consolidated Equity Method Investment in ICPtruefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$D2013Q2QTDhttp://www.sec.gov/CIK0000835011duration2013-04-01T00:00:002013-06-30T00:00:00usdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$D2012Q2QTDhttp://www.sec.gov/CIK0000835011duration2012-04-01T00:00:002012-06-30T00:00:00usdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$D2013Q2YTDhttp://www.sec.gov/CIK0000835011duration2013-01-01T00:00:002013-06-30T00:00:00usdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$D2012Q2YTDhttp://www.sec.gov/CIK0000835011duration2012-01-01T00:00:002012-06-30T00:00:00usdStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2mgpi_IcpSOperatingResultsAbstractmgpi_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0ICP’s Operating results:2false 3us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenueus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse6137700061377[1]USD$falsetruefalse2truefalsefalse5893800058938[1]USD$falsetruefalse3truefalsefalse9422700094227[1]USD$falsetruefalse4truefalsefalse116991000116991[1]USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe amount of revenue from sale of goods and services reduced by sales returns, allowances, and discounts reported by an equity method investment of the entity.No definition available.false2Net sales3false 3mgpi_EquityMethodInvestmentSummarizedFinancialInformationCostOfSalesAndExpensesmgpi_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-61034000-61034[2]falsefalsefalse2truefalsefalse-59307000-59307[2]falsefalsefalse3truefalsefalse-97114000-97114[2]falsefalsefalse4truefalsefalse-116232000-116232[2]falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of the cost of sales and expenses reported by an equity method investment of the entity.No definition available.false2Cost of sales and expenses4false 3us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse343000343USD$falsetruefalse2truefalsefalse-369000-369USD$falsetruefalse3truefalsefalse-2887000-2887USD$falsetruefalse4truefalsefalse759000759USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe amount of net income (loss) reported by an equity method investment of the entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(g)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph g -Subparagraph 1, 2 -Article 4 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph w -Article 1 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 18 -Paragraph 20 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 159 -Paragraph 18 -Subparagraph f -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph bb -Article 1 true2Net income (loss)1Includes related party sales to MGPI of $741 and $14,638 for the quarters ended June 30, 2013 and 2012, respectively, and $3,400 and $30,633 for the year to date periods ended June 30, 2013 and 2012, respectively.2Includes depreciation and amortization of $1,170 and $1,259 for the quarters ended June 30, 2013 and 2012, respectively and $2,340 and $2,519 for the year to date periods ended June 30, 2013 and 2012, respectively.falseEquity Method Investments (Detail) - Condensed Financial Information of the Company's Non-Consolidated Equity Method Investment in ICP (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.mgpingredients.com/role/EquityMethodInvestmentsDetailCondensedFinancialInformationOfCompanysNonConsolidatedEquityMethodInvestmentInIcp44